Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia

TY - JOUR

T1 - Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia

AU - South Asian Ibd Alliance Board Of Directors

AU - Balasubramaniam, Madhura

AU - Nandi, Neilanjan

AU - Aswani-Omprakash, Tina

AU - Sebastian, Shaji

AU - Sharma, Vishal

AU - Deepak, Parakkal

AU - Bishu, Shrinivas

AU - Shah, Neha D.

AU - Bhatia, Sumit

AU - Ali, Tauseef

AU - Khela, Sharan

AU - Peddi, Kiran

N1 - Funding Information: Funding Parakkal Deepak is supported by a Junior Faculty Development Award from the American College of Gastroenterology and IBD Plexus of the Crohn's & Colitis Foundation . Funding Information: Conflicts of Interest These authors disclose the following: Neilanjan Nandi has received consulting fees from Pfizer, Janssen, Boehringer Ingelheim, and Bristol Myers Squibb. Tina Aswani-Omprakash has received speaker fees from or served as a consultant or on an advisory board for Janssen, Boehringer Ingelheim, AbbVie, Arena Pharmaceuticals (now Pfizer), Takeda, Genentech-Roche, Celgene (now Bristol Myers Squibb), and Hollister, Inc. Shaji Sebastian holds research grants from Biogen, Takeda, AbbVie, Tillotts Pharma, Pfizer, Janssen, MedTronic, Ferring, and Biohit; served on the advisory boards of Takeda, AbbVie, Merck, Ferring, Pharmacocosmos, Warner Chilcott, Janssen, Falk Pharma, Biohit, TriGenix, Celgene, and Tillots Pharma; and has received speaker fees from AbbVie, Biogen, AbbVie, Janssen, Merck, Warner Chilcott, and Falk Pharma. Neha D. Shah is a consultant for GI on Demand (American College of Gastroenterology and Gastro Girl). Sumit Bhatia has received speaker fees from and served on the advisory boards of Johnson and Johnson, Abbott, Takeda India, Dr. Reddy's Laboratories, MSN pharma, and Zydus Pharma. Parakkal Deepak has received research support under a sponsored research agreement unrelated to the data in the article and/or consulting from AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Pfizer, Prometheus Biosciences, Takeda Pharmaceuticals, Scipher Medicine, and CorEvitas, LLC. Tauseef Ali has received speaker's fees from, served on the advisory boards of, and consulted for AbbVie, Janssen, Takeda, Pfizer, Bristol Myers Squibb, and Boehringer Ingelheim. The remaining authors disclose no conflicts.Funding Parakkal Deepak is supported by a Junior Faculty Development Award from the American College of Gastroenterology and IBD Plexus of the Crohn's & Colitis Foundation.

PY - 2022/11

Y1 - 2022/11

UR - http://www.scopus.com/inward/record.url?scp=85139867889&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2022.09.007

DO - 10.1016/j.cgh.2022.09.007

M3 - Editorial

C2 - 36307171

AN - SCOPUS:85139867889

SN - 1542-3565

VL - 20

SP - 2421

EP - 2426

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 11

ER -